Cargando…

Cytotoxic Xanthone-Anthraquinone Heterodimers from an Unidentified Fungus of the Order Hypocreales (MSX 17022)

Two new xanthone-anthraquinone heterodimers, acremoxanthone C (5) and acremoxanthone D (2), have been isolated from an extract of an unidentified fungus of the Order Hypocreales (MSX 17022) by bioactivity-directed fractionation as part of a search for anticancer leads from filamentous fungi. Two kno...

Descripción completa

Detalles Bibliográficos
Autores principales: Ayers, Sloan, Graf, Tyler N., Adcock, Audrey F., Kroll, David J., Shen, Qi, Swanson, Steven M., Matthew, Susan, Carcache de Blanco, Esperanza J., Wani, Mansukh C., Darveaux, Blaise A., Pearce, Cedric J., Oberlies, Nicholas H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3267898/
https://www.ncbi.nlm.nih.gov/pubmed/22068158
http://dx.doi.org/10.1038/ja.2011.95
Descripción
Sumario:Two new xanthone-anthraquinone heterodimers, acremoxanthone C (5) and acremoxanthone D (2), have been isolated from an extract of an unidentified fungus of the Order Hypocreales (MSX 17022) by bioactivity-directed fractionation as part of a search for anticancer leads from filamentous fungi. Two known related compounds, acremonidin A (4) and acremonidin C (3) were also isolated, as was a known benzophenone, moniliphenone (1). The structures of these isolates were determined via extensive use of spectroscopic and spectrometric tools in conjunction with comparisons to the literature. All compounds (1–5) were evaluated against a suite of biological assays, including those for cytotoxicity, inhibition of the 20S proteasome, mitochondria transmembrane potential, and NF-κB.